Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
Collectively, these findings suggest that for patients receiving PTCy, the hierarchy of donor selection factors might have evolved, allowing for greater flexibility in donor choice. Our findings provide a solid foundation for future larger external validation studies.
Authors
- Katayoun Rezvani (ORCID: https://orcid.org/0000-0002-9599-2246)
- Gabriela Rondón (ORCID: https://orcid.org/0000-0003-3841-3567)
- Rohtesh S. Mehta (ORCID: https://orcid.org/0000-0002-8532-544X)
- U. Popat
- P. Kebriaei
- Amanda Olson (ORCID: https://orcid.org/0000-0002-1669-0355)
- Betul Oran
- Richard E. Champlin
- Chitra Hosing
- Elizabeth J. Shpall
- Yosra M. Aljawai
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1200/op-25-00675
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00